Millennium Management
OLMA icon

Millennium Management’s Olema Pharmaceuticals OLMA Stock Holding History

Millennium Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$276K – 7203
2021
Q3 		$276K Buy
+10,000
New +$270K ﹤0.01% 5875

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Millennium Management's OLMA Position: Q1 2026 in Review

Millennium Management reduced its Olema Pharmaceuticals (OLMA) stake by 63% in Q1 2026, selling an estimated $7.02M and leaving 182,935 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Millennium Management first reported a position in OLMA in Q4 2020 and has held it in 18 quarters since. The position peaked at $12.5M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Millennium Management held 182,935 shares of Olema Pharmaceuticals worth $2.73M as of Q1 2026.
  • Millennium Management sold 315,555 Olema Pharmaceuticals shares in Q1 2026, an estimated $7.02M.
  • Olema Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3569 holding.
  • Millennium Management first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Millennium Management's Olema Pharmaceuticals position peaked at $12.5M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.